Vanda Pharmaceuticals (VNDA) Interest Coverage Ratio (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Interest Coverage Ratio of 6.32 for Q1 2026, down 7.92% on a YoY basis from 6.86 in Q1 2025, and up 57.75% sequentially from 14.96 in Q4 2025.
Vanda Pharmaceuticals (VNDA) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of Interest Coverage Ratio data on file, last reported at 6.32 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 7.92% year-over-year to 6.32; the trailing twelve-month figure through Mar 2026 stood at 20.18 (down 95.13% YoY), and the FY2025 full-year result was 1.22, up 73.44% from the prior year.
- Interest Coverage Ratio improved to 6.32 in Q1 2026, from 14.96 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.69 in Q3 2022 to a low of 14.96 in Q4 2025.
- A 5-year average of 2.75 and a median of 1.57 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio soared 231.39% in 2022 and tumbled 1193.12% in 2025, its largest moves.
- Tracing VNDA's Interest Coverage Ratio over 5 years: stood at 0.93 in 2022, then slumped by 189.35% to 0.83 in 2023, then tumbled by 39.35% to 1.16 in 2024, then plunged by 1193.12% to 14.96 in 2025, then jumped by 57.75% to 6.32 in 2026.
- Business Quant data shows VNDA's Interest Coverage Ratio at 6.32 in Q1 2026, 14.96 in Q4 2025, and 4.46 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -6.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.32 |
| Dec 31, 2025 | -14.96 |
| Sep 30, 2025 | -4.46 |
| Jun 30, 2025 | -5.49 |
| Mar 31, 2025 | -5.86 |
| Dec 31, 2024 | -1.16 |
| Sep 30, 2024 | -1.57 |
| Jun 30, 2024 | -1.45 |
| Mar 31, 2024 | -1.32 |
| Dec 31, 2023 | -0.83 |
| Sep 30, 2023 | -4.10 |
| Jun 30, 2023 | -1.89 |
| Mar 31, 2023 | 1.32 |
| Dec 31, 2022 | 0.93 |
| Sep 30, 2022 | 1.69 |
| Jun 30, 2022 | 1.31 |
| Mar 31, 2022 | -2.53 |
| Dec 31, 2021 | 1.23 |
| Sep 30, 2021 | 0.63 |
| Jun 30, 2021 | 0.40 |